Page 14 - Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of cytoreductive nephrectomy for patients with metastatic renal cell carcinoma

CUAJ – Consensus Statement Mason et al
KCRNC consensus: Cytoreductive nephrectomy for mRCC

43. Rini BI, Garcia J, Elson P, Wood L, Shah S, Stephenson A, et al. The effect of
sunitinib on primary renal cell carcinoma and facilitation of subsequent surgery. J
Urol. 2012;187:1548-54.
44. Wood CG, Margulis V. Neoadjuvant (presurgical) therapy for renal cell
carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Cancer. 2009;115:2355-60.
45. Stroup SP, Raheem OA, Palazzi KL, Liss MA, Mehrazin R, Kopp RP, et al. Does
timing of cytoreductive nephrectomy impact patient survival with metastatic renal
cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional study.
Urology. 2013;81:805-11.
46. Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH,
et al. Comparative Survival Following Initial Cytoreductive Nephrectomy Versus
Initial Targeted Therapy for Metastatic Renal Cell Carcinoma. J Urol. 2018.
47. Rini BI, Dorff TB, Elson P, Rodriguez CS, Shepard D, Wood L, et al. Active
surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial.
Lancet Oncol. 2016;17:1317-24.
48. Verzoni E, Ratta R, Grassi P, Salvioni R, Stagni S, Montone R, et al. TARIBO
trial: targeted therapy with or without nephrectomy in metastatic renal cell
carcinoma: liquid biopsy for biomarkers discovery. Tumori. 2017:0.
49. Clinical Trial to Assess the Importance of Nephrectomy.
50. Marchioni M, Bandini M, Preisser F, Tian Z, Kapoor A, Cindolo L, et al. Survival
after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell
Carcinoma Patients: A Population-based Study. Eur Urol Focus. 2017;08:08.
51. Carrasco A, Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Boorjian SA.
The impact of histology on survival for patients with metastatic renal cell
carcinoma undergoing cytoreductive nephrectomy. Indian J. 2014;30:38-42.
52. Aizer AA, Urun Y, McKay RR, Kibel AS, Nguyen PL, Choueiri TK.
Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell
carcinoma (RCC). BJU Int. 2014;113:E67-74.
53. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, et
al. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear
cell histology. J Urol. 2007;178:1896-900.
54. Jeffrey Graham CW, Frede Donskov, Jae-Lyun Lee, Anna Paola Fraccon, Felice
Pasini, Camillo Porta, I. Alex Bowman, Georg A. Bjarnason, D. Scott Ernst, Sun
Young Rha, Benoit Beuselinck, Aaron Richard Hansen, Scott A. North, Christian
K. Kollmannsberger, Lori Wood, Ulka N. Vaishampayan, Sumanta K. Pal, Toni
K. Choueiri, Daniel Yick Chin Heng. Cytoreductive nephrectomy in metastatic
papillary renal cell carcinoma: Results from the International Metastatic Renal